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number of primordial oocytes or reduced
fertility after prenatal exposure to inorganic
lead (1-3), benzo[alpyrene (BaP) (4), and
other agents (5,6). Inorganic lead is also a
suspected developmental neurotoxicant (7)
and could possibly have adverse effects on
the developing reproductive system
through action on the hypothalamic-pitu-
itary axis during fetal life. Studies exploring
if similar mechanisms may be responsible
for human subfeecundity are scarce; in an
epidemniologic study maternal smoking in
the pregnancy was associated with reduced
fecundability among their daughters in
later life (8).
The reproductive effects of environ-
mental pollutants are currently receiving
attention, due in part to the possibility of
human infertility (9). BaP and inorganic
lead are ofspecial interest. Both are ubiqui-
tous environmental pollutants, and BaP is a
component of cigarette smoke. We there-
fore conducted an experiment exposing
mice prenatally to inorganic lead and BaP.
The purpose ofthe study was to investigate
lead and BaP for synergistic effects on
female fertility. We chose a treatment dose
of lead that was judged from the blood
lead levels to be comparable to exposure
levels found in many occupational settings.
The treatment dose of BaP was similar to
the lowest dose that induced subfertility in
an earlier report (4).
Methods
Lead(II) chloride (CAS no. 7758-95-4)
was supplied from Baker (Deventer,
Holland). Benzo[a]pyrene (CAS no. 50-
32-8) was a product of Sigma Chemical
Company (St. Louis, Missouri).
Male and FO female Bom:NMRI mice
were acclimatized to a 12/12 hr light/dark
cycle (lights on at 0600 hr) at 24 ± 1VC.
Laboratory chow (EWOS, R34) and tap
water were provided ad libitum. Males
were individually caged except during mat-
ing. We placed Fo females in groups of
three until the last week of pregnancy
when they were caged alone.
At the age of9 weeks, Fo females were
randomly assigned to one of four treat-
ment groups, nine mice per group. Two
groups received tap water with 1 g
PbCl2/L(0.75 g Pb) during the 6 weeks
before mating, whereas the remaining two
groups received tap water without any
additions. We discontinued the lead treat-
ment before mating to avoid exposure of
the males. All FO females were caged with
sexually active males. Females were
inspected twice daily for a vaginal plug,
which, in case of pregnancy, was counted
as day 0 ofgestation. During days 7-16 of
pregnancy, one ofthe tap water groups and
one of the lead-water groups received a
daily treatment of0.2 mL corn oil BaP (10
mg/kg body weight by oral intubation),
and the remaining two groups received
corn oil. Thus, the four treatment groups,
each comprising nine Fo females, were the
control group, the lead group, the BaP
group, and the lead plus BaP group. We
recorded weights and sampled blood for
lead measurement from tail veins on the
day before cagingwith the males (Table 1).
Assessed from a pilot trial on female mice
ofthe same strain, the blood lead values in
the lead-treated groups should give values
of approximately 2 pmol/L 10 days later
(during the second week of pregnancy).
No F0 females showed signs ofgeneral tox-
icity, and they all proved fertile. We kept
F0 females with their offspring until after
weaning (21 days after delivery).
One F1 female from each ofthe 36 lit-
ters was allocated in the experiment, each
belonging to one of the four exposure
groups they had been assigned to in utero.
At the age of 6 weeks, each F, female was
caged for 6 months with an untreated
male proven to be sexually active. Males
for four females that did not become preg-
nant after 30 days were replaced, but this
procedure did not lead to any pregnancies.
Dates and sizes oflitters were recorded. F2
offspring were inspected for gross deformi-
ties at birth, and their weight and sex were
recorded at day 2 after birth when they
were killed by cervical dislocation.
After 6 months of continuous breed-
ing, the F1 females were euthanized; the
right ovary was excised, trimmed, and
weighed. Ovaries were fixed in buffered
formalin, embedded in paraffin, and 3-pm
parasagittal sections were prepared. Three
slides, made from tissue 90 pm apart, were
stained with hematoxylin-azophloxine-saf-
fron and reticulin and examinated by light
microscopy.
The F1 female was taken as the basic
unit of experimentation. Several measures
of fertility and ovarian morphology were
recorded without knowledge of the treat-
ment group. Measures of fertility for each
F1 female were number ofoffspring, num-
ber of litters during the breeding period,
median litter size, and median days
between deliveries (with the start of the
experiment as the starting point for the
first interval).
We recorded the weight of the right
ovary for each F1 female and counted fol-
licles and corpora lutea in the three histo-
logical sections. Follicles were classified
according to Pedersen and Peters (10).
Treatment effects on fertility, ovarian
weights, and counts in the microscopic
examination were evaluated by nonpara-
metric tests (Wilcoxon rank sum test,
Kruskall-Wallis test). Significance levels of
<0.05 (two-tailed) were taken as criterion
oftreatment effects. The statistical analyses
were performed with the BMDP software
package (11).
Results
The 36 mated F1 females gave birth to a
total of 1985 offspring distributed over
182 litters. The distribution over the treat-
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Table 1. Descriptive values (median, range) forFo and F1 female mice in the fourtreatment groups
Treatment group
Control
Lead
BaP
Lead plus BaP
Heterogeneity between
groups,X2 (p)
Bodyweight attime of ma
Median Ra
37.8 34.6
36.5 33.3
35.9 32.8
37.9 32.7
0.93 (0.82)
Fofemales (n = 9/group)
3ting (g) Blood lead attime of mating (pmol/L)
inge Median Range
41.4 0.04 0.01-0.10
-43.9 3.37 2.44-3.80
-40.3 0.04 0.02-0.08
-46.3 3.71 2.70-5.26
27.3 (<0.0001)
F1 females (n= 9/group)
Body weight after first pregnancy (g)
Median Range
38.7 37.3-43.9
39.8 37.9-44.7
37.1 34.1-44.3
38.0 32.9-44.7
1.98 (0.58)
BaP, benzo[alpyrene.
aChi-square with 3 degrees offreedom; two-tailed p-value.
Table 2. Values of different measures offertility overthe four treatment groups among F1 female mice
Control
Treatment group
Lead BaFP
Effect (n=9) (n=9) (n=
No. oflitters 67 72 29
No. ofoffspring (stillborn) 785(4) 860(8) 248(8
Median no.offspring/Fl (range) 92(26-121) 95(50-122) 22*
Median no. litters/F1 (range) 8(3-8) 8(8-8) 3**
Median littersize/F1 (range) 11.5 (6-15) 13(6-18) 8**
Median no. days between 20.5(20-21) 20.5(20-21) 21*
litters/F, (range)
BaP,benzo[alpyrene.
aChi-square with 3 degrees offreedom; two-tailed p-value.
*Significantly different from control group (two-tailed p < 0.05).
**Significantly differentfrom control group (two-tailed p<0.005).
ment groups is given in Table 2. The lead The
group had litters and offspring numbers highly s
that were slightly higher than the control treatmer
group, whereas the BaP group and the lead number
plus BaP group both had considerably median
lower fertility as judged by these measures. days betn
The cumulative number of F2 offspring to mark
over time and the distribution of number BaP anm
of litters among F1 females in the four pared tc
treatment groups are illustrated in Figures lead gro
1 and 2, respectively. Four F1 females (one ter than
BaP treated, three lead plus BaP treated) In the c
were infertile in the study; only 1 out of 18 and the
F1 females producing more than 6 litters showed
belonged to either of the 2 groups receiv- Some ol
ing BaP (Fig. 2). were or
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Figure 1. Cumulative number of F2 offspring
recorded over 6 months for the four F1 treatment
groups.
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recorded
four treaty
3)
2
9)
10-86)
10-8)
(3-11)
0-23)
Lead plus BaP
(n=9)
14
92(9)
4**(0-48)
2**(0-5)
6.5**(1-12)
22.5**(21-29)
Heterogeneity
between groups,
X2(P)a
24.5(<0.0001)
22.8 (<0.0001)
10.6(0.01)
15.5(0.001)
Kruskall-Wallis test demonstrated
significant heterogeneity over the
nt group for all measures offertility:
of offspring, number of litters,
number ofoffspring per litter, and
.ween litters (Table 2). This was due
edly lower fertility measures in the
d the lead plus BaP groups com-
o the control group, whereas the
up performed nonsignificantly bet-
the control group for all measures.
omparison between the BaP group
lead plus BaP group, the latter
poorer fertility for all measures.
of those differences were large but
nly significant for median days
litters (Z-value = 1.98, two-tailed
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Frequency distribution of total litters
Iover 6 months among F1 females in the
tment groups.
p = 0.05). For other effect measures, the
significance levels ranged from 0.09 to
0.32.
A similar pattern was evident from
examination of the ovaries (Table 3).
Ovary weights, counts of follicles, and
counts of corpora lutea were different in
the treatment groups, with low weights
and depletion offollicles and corpora lutea
for most animals in the BaP and lead plus
BaP groups. The F1 females in the lead
group had nonsignificantly higher weights
and counts of follicles and corpora lutea
compared to the control group. The lead
plus BaP group had lower counts of folli-
cles and corpora lutea and slightly higher
median ovarian weight than the BaP
group, but all differences were nonsignifi-
cant in the Wilcoxon rank sum test.
Discussion
We have shown that prenatal administra-
tion of 10 mg BaP/kg maternal bodyweight
(with or without lead) leads to subfertility
and a marked reduction in the number of
ovarian follicles in F1 females. These results
are in agreement with a previous report (4)
and are probably due to impaired develop-
ment ofprimordial oocytes. This interpreta-
tion is further supported by an earlier report
on toxic effects of BaP on primordial
oocytes in weanling mice (12).
No treatment effects of lead were
detected in the study. This is not surpris-
ing since we used moderate doses resulting
in maternal blood lead levels about 2
pmol/L during the second week of preg-
nancy; this is considered to be the critical
time offetal folliculogenesis (3). This dose
was far lower than that reported to have an
independent effect on primordial germ
cells (3) and fertility (1-3).
To our knowledge, the combined effect
on fertility of inorganic lead and BaP has
not been reported earlier. Our study was
designed to investigate the hypothesis ofan
interaction between the two agents. We
found a synergistic action ofinorganic lead
on the BaP effects for days between litters,
and the manifestations of combined lead
and BaP treatment were stronger, but not
Volume 103, Number 6, June 1995 589WA base-
Table3. Values of different measures of ovarian effects overthe fourtreatment groups among F female micea
Median (range)
Control Lead BaP Lead plus BaP
Effect (n= 9) (n = 7) (n = 8) (n= 8) Heterogeneity between groups,X2 pb
Ovarian weight (mg) 13 (13-20) 14(11-25) 9* (7-13) 10 (2-17) 12.4 (0.006)
No. ofsmallfollicles/F1 44 (1-137) 60.5 (15-150) 0**(0-68) 0**(0-35) 18.8 (0.0003)
No. of medium follicles/F1 9(5-25) 12.5 (2-30) 0** (0-57) 0** (0-2) 19.3 (0.0002)
No. of largefollicles/F1 14 (6-23) 21.5 (12-29) 0** (0-19) 0** (0-0) 23.6 (0.0001)
No. of corpora lutea/F1 16 (6-35) 22 (15-57) 0** (0-14) 0**(0-4) 23.4 (<0.0001)
BaP, benzo[a]pyrene.
aHistologic examinations were performed on three sections ofthe right ovary. Results were discarded for two animals in the lead group and one animal each in
the BaP and the BaP plus lead-treated groups.
bChi-square with 3 degrees offreedom; two-tailed p-value.
*Significantly differentfrom control group (two-tailed p<0.05).
**Significantly differentfrom control group(two-tailed p<0.005).
significantly so, for almost all indicators of
impaired follicular development and fertili-
ty compared to the BaP treatment alone. It
may be relevant that some lead compounds
have synergistic effects on model carcino-
gens in rodents (13-16).
Mechanistic interpretations on the syn-
ergism between lead and BaP on the basis
ofour results can only be speculative. BaP
seems to have a direct effect on primordial
oocytes (4,i). Fetal treatment with high
doses of inorganic lead also decreases the
number of primordial follicles, possibly as
an effect on the migration or multiplica-
tion ofthe developing germ cells (2). Lead
is also a developmental neurotoxicant, and
its synergistic action might be explained by
a disturbance of the neuroendocrine bal-
ance that alone was not sufficient to impair
fertility. However, Wide (2) found only
small and nonsignificant alterations in the
levels ofovarian steroid hormones for mice
exposed prenatally to lead in doses that
clearly reduced the number of primordial
follicles.
The lead and BaP doses chosen in our
study were probably not optimal. The lead
dose was comparable to human exposures,
and the daily BaP dose in our study was
equal to the lowest effect level in an earlier
study, but its effect on fertility was strong
(4). The daily dose (10 mg/kg) is about 1
million times the main stream dose in 100
cigarettes (12). Fertility as outcome might
have been more sensitive to the combined
effects oflead and BaP ifthe BaP dose had
been lower. BaP alone had a profound
effect; even ifthe lead plus BaP group had
almost total depletion offollicles and sever-
al animals were infertile, the differences
were not significant.
There is currently much concern about
human fertility (9). Biology indicates that
the prenatal development of primordial
germ cells may be crucial. Exposures to
common environmental xenobiotics are
under suspicion ofinterfering with gonadal
development (9). Human exposures from
environmental sources are considerably
lower than exposures producing effects in
laboratory animals but could be more rele-
vant in case ofsynergistic actions. Human
studies addressing effects ofenvironmental
agents are warranted, but the needed
multigenerational designs restrict the possi-
bilities (18). Animal models that have been
developed should be further applied.
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